News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
SITC – JITC Has Reached an Impact Factor of 10.6 and a CiteScore of 17.8 in 2024!
Society for Immunotherapy of Cancer/sitcancer.org
Jul 3, 2025, 08:20

SITC – JITC Has Reached an Impact Factor of 10.6 and a CiteScore of 17.8 in 2024!

Society for Immunotherapy of Cancer (SITC) posted on LinkedIn:

“SITC is proud to share that the Journal for ImmunoTherapy of Cancer (JITC) has reached an Impact Factor of 10.6 and a CiteScore of 17.8 in 2024!

As an open access, peer-reviewed journal, JITC is committed to serve as a targeted outlet for the publication of original research articles, literature reviews, position papers and discussion on all aspects of tumor immunology and cancer immunotherapy–from basic research to clinical application.

Explore the latest high-impact articles:

1. Single-cell RNA sequencing of baseline PBMCs predicts ICI efficacy and irAE severity in patients with NSCLC.

Authors: Gyeong Dae Kim, So-I Shin, Pureum Sun, Jeong Eun Lee, Chaeuk Chung, Yea Eun Kang, Da Hyun Kang, Jihwan Park

2. EZH2 inhibition and 5-azacytidine enhance antitumor immunity in PTEN-deficient glioblastoma by activation viral mimicry response.

Authors: Dandan Zhu, Zeying Li, Huolun Feng, Jiabin Zheng, Xiao Xiao, Zuda Huang, Liangying Zheng, Jieqing Guo, Fa Ling, Yong Li, Fan Xing

3. Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy.

Authors: Salomé S. Pinho, Matthew S. Macauley, Heinz Läubli

4. Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors.

Authors: Alia D Zander, Rossin Erbe, Yan Liu, Ailin Jin, Seung Won Hyun, Sayantoni Mukhopadhyay, Ben Terdich, Mario G Rosasco, Nirali Patel, Brett M Mahon, A Kate Sasser, Michelle A Ting-Lin, Halla Nimeiri, Justin Guinney, Douglas Adkins, Matthew Zibelman, Kyle A Beauchamp, Chithra Sangli, Michelle M Stein, Timothy Taxter, Timothy Chan, Sandip P Patel, Ezra E W Cohen.”

More posts featuring Society for Immunotherapy of Cancer.

Chaeuk Chung Da Hyun Kang Dandan Zhu Fa Ling Fan Xing Gyeong Dae Kim Heinz Läubli Huolun Feng Jeong Eun Lee Jiabin Zheng Jieqing Guo Jihwan Park JITC Liangying Zheng Matthew S. Macauley NSCLC Pureum Sun Salomé S. Pinho So-I Shin Society for Immunotherapy of Cancer Xiao Xiao Yea Eun Kang Yong Li Zeying Li Zuda Huang
Special Coverage
Blog
Jul 19, 2025, 09:24
Herbert Loong: A Multi-Agent AI-Assisted System Designed for Clinical Trials Matching
Blog
Jul 19, 2025, 09:05
Luigi Lorini: Wonderful Opportunities for Exchange and Collaboration
Blog
Jul 19, 2025, 08:54
Jennifer Bires: Psychedelic-Assisted Therapy for Adults with Cancer
Positive
Jul 19, 2025, 07:24
Strengthening Public Health: Cyprus Donates Lifesaving Medicines to Botswana
Dialogues
Jul 19, 2025, 07:23
Empowering Oncologists: Evolving role of AI in Oncology
Drugs
Jul 19, 2025, 07:22
Datopotamab deruxtecan-dlnk (Datroway) 2025 Guides: What Patients Need to Know?
Insight
Jul 19, 2025, 07:21
Wafik El-Deiry: Collaboration in US and Global Fight Against Cancer
Drugs
Jul 19, 2025, 07:08
Datopotamab Deruxtecan-dlnk (Datroway) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and More
Blog
Jul 19, 2025, 02:39
Alisher Kahharov: Training at the Prestigious Saint-Louis Hospital in Paris
Blog
Jul 19, 2025, 02:07
Bernard A. Fox: Back in Taiwan - Sharing the Next Frontier in Cancer Immunotherapy at Grand Rounds
Blog
Jul 19, 2025, 02:00
Akash Maniam: How Best to De-Escalate Excellent Responders and Intensify Those Who Don't
Career
Jul 18, 2025, 22:12
Sosipatros Boikos Joins the Life Raft Group As An External Consultant Medical Oncologist